NS 1738 (NSC-213859) is a selective positive allosteric modulator of alpha7 nicotinic acetylcholine receptors. It enhances receptor function and is utilized in research on cognitive disorders, schizophrenia, and neuroprotection, supporting both in vitro electrophysiology and in vivo behavioral studies.